Lung Cancer
Volume 58, Issue 3 , Pages 329-341 , December 2007

Long-term follow-up study of a population-based 1996–1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography

  • Shusuke Sone

      Affiliations

    • Department of Radiology, JA Nagano Azumi General Hospital, Ikeda, Nagano 399-8695, Japan
    • Present address: Nagano Health Promotion Corporation, Nagano 381-2298, Japan.
    • Corresponding Author InformationCorresponding author at: Okada Matsuoka 88-4, Matsumoto 390-0312, Japan. Tel.: +81 263 46 6022; fax: +81 263 46 6022.
    • ,
  • Tomio Nakayama

      Affiliations

    • Division of Epidemiology, Department of Field Research, Osaka Medical Centre for Cancer and Cardiovascular Diseases, Higashinari-ku, Osaka 537-8511, Japan
    • ,
  • Takayuki Honda

      Affiliations

    • Department of Laboratory Medicine, Shinshu University School of Medicine, Matsumoto 390-864, Japan
    • ,
  • Kenji Tsushima

      Affiliations

    • Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-864, Japan
    • ,
  • Feng Li

      Affiliations

    • Kurt Rossmann Laboratories for Radiologic Image Research, Department of Radiology, The University of Chicago, Chicago, IL 60637, USA
    • ,
  • Masayuki Haniuda

      Affiliations

    • Department of Surgery, Division of Chest Surgery, Aichi Medical University, Aichi 480-1195, Japan
    • ,
  • Yoshiro Takahashi

      Affiliations

    • Enchiku Branch, Nagano Medical Association, Shiojiri 399-0734, Japan
    • ,
  • Takaichiro Suzuki

      Affiliations

    • Division of Epidemiology, Department of Field Research, Osaka Medical Centre for Cancer and Cardiovascular Diseases, Higashinari-ku, Osaka 537-8511, Japan
    • ,
  • Takeshi Yamanda

      Affiliations

    • Department of Surgery, Division of Chest Surgery, National Chushin Matsumoto Hospital, Matsumoto 399-0021, Japan
    • ,
  • Ryoichi Kondo

      Affiliations

    • Department of Surgery, Shinshu University School of Medicine, Matsumoto 390-864, Japan
    • ,
  • Takaomi Hanaoka

      Affiliations

    • Department of Chest Surgery, JA Nagano Azumi General Hospital, Ikeda, Nagano 399-8695, Japan
    • ,
  • Fumiyoshi Takayama

      Affiliations

    • Department of Radiology, JA Nagano Azumi General Hospital, Ikeda, Nagano 399-8695, Japan
    • ,
  • Keishi Kubo

      Affiliations

    • Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-864, Japan
    • ,
  • Hajime Fushimi

      Affiliations

    • Nagano Health Promotion Corporation, Nagano 381-2298, Japan

Received 17 March 2007 ,Revised 22 June 2007 ,Accepted 28 June 2007.

References 

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–130
  2. Soda H, Tomita H, Kohno S, Oka M. Limitation of annual screening chest radiography for the diagnosis of lung cancer. Cancer. 1993;72:2341–2346
  3. Sagawa M, Nakayama T, Tsukada H, Nishii K, Baba T, Kurita Y, et al. The efficacy of lung cancer screening conducted in 1990s: four case-control studies in Japan. Lung Cancer. 2003;41:29–36
  4. Sone S, Li F, Yang Z-G, Honda T, Maruyama Y, Takashima S, et al. Characteristics of small lung cancers invisible on conventional chest radiography and detected by population based screening using spiral CT. Br J Radiol. 2000;73:137–145
  5. The International Early Lung Cancer Action Program Investigators. Survival of patients with Stage I lung cancer detected on CT screening. N Engl J Med. 2006;355:1763–1771
  6. Sone S, Takashima S, Li F, Yang Z, Honda T, Maruyama Y, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet. 1998;351:1242–1245
  7. Sone S, Li F, Yang Z, Takashima S, Maruyama Y, Hasegawa M, et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer. 2001;84:25–32
  8. Sone S, Nakayama T, Honda T, Tsushima K, Li F, Haniuda M, et al. CT findings of early-stage small cell lung cancer in a low-dose CT screening programme. Lung Cancer. 2007;56:207–215
  9. Heitzman ER. Bronchogenic carcinoma: radiologic-pathologic correlations. Semin Roentgenol. 1977;12:165–174
  10. Zwirewich CV, Vedal S, Miller RR, Muller NL. Solitary pulmonary nodule: high resolution CT and radiologic-pathologic correlation. Radiology. 1991;179:469–476
  11. Sone S, Sakai F, Takashima S, Honda T, Yamanda T, Kubo K, et al. Factors affecting the radiologic appearance of peripheral bronchogenic carcinomas. J Thorac Imaging. 1997;12:159–172
  12. Hasegawa M, Sone S, Tahashima S, Li F, Yang Z-G, Maruyama Y, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol. 2000;73:1252–1259
  13. Swensen SJ, Brown LR, Colby TV, Weaver AL, Midthun DE. Lung nodule enhancement at CT: Prospective findings. Radiology. 1996;201:447–455
  14. Gückel C, Schnabel K, Deimling M, Steinbrich W. Solitary pulmonary nodules: MR evaluation of enhancement patterns with contrast-enhanced dynamic snapshot gradient-echo imaging. Radiology. 1996;200:681–686
  15. Hittmair K, Eckersberger F, Klepetko W, Helbich T, Herold C. Magn Reson Med. 1995;13:923–933
  16. In:  Travis WD,  Brambilla E,  Müller-Helmelink HK,  Harris CC editor. World Health Organization classification of tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press; 2004;
  17. Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710–1717
  18. SAS Institute Inc. . 4th ed.. SAS/STAT User's Guide, Version 6. vol. 2. SAS Institute Inc.; 1989;
  19. Martini N, Melamed MR. Multiple primary lung cancers. J Thoracic Cardiovasc Surg. 1975;20:606–612
  20. Pasini F, Verlato G, Durante E, de Manzoni G, Valduga F, Accordini S, et al. Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years. Br J Cancer. 2003;88:1666–1668
  21. Batevik R, Grong K, Segadal L, Stangeland L. The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: a study of absolute and relative survival over 15 years. Lung Cancer. 2005;47:173–181
  22. Zatloukal P, Kubík A, Pauk N, Tomášek L, Petruzelka L. Adenocarcinoma of the lung among women: risk associated with smoking, prior lung disease, diet and menstrual and pregnancy history. Lung Cancer. 2003;41:283–293
  23. Mazzone PJ, Mekhail T, Arroliga AC. Is lung cancer in the nonsmokers a different disease?. Chest. 2004;126:326–329
  24. Nordquist LK, Simon GR, Canter A, Alberts M, Bepler G. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest. 2004;126:347–351
  25. Sobue T, Suzuki T, Fujimoto I, Doi O, Tateishi R, Sato T. Prognostic factors for surgically treated lung adenocarcinoma patients, with special reference to smoking habit. Jpn J Cancer Res. 1991;82:33–39
  26. Li F, Sone S, Abe H, MacMahon H, Armato SG, Doi K. Lung cancers missed at low-dose helical CT screening in a general population: comparison of clinical, Histopathologic, and imaging findings. Radiology. 2002;225:673–683
  27. Yankelevitz DF, Henschke CI. Does 2-year stability imply that pulmonary nodules are benign. AJR. 1997;168:325–328
  28. Yankelevitz DF, Reeves AP, Kostis WJ, Zhao Binsheng , Henschke CI. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology. 2000;217:251–256
  29. Bach PB, Kelley MJ, Ramsey C, Tate RC, McCrory DC. Screening for lung cancer. A review of the current literature. Chest. 2003;123:72S–82S
  30. Sobue T, Suzuku T, Matsuda M, Kuroishi T, Ikeda S, Naruke T, et al. Survival for clinical stage I lung cancer not surgically treated. Cancer. 1992;69:685–692
  31. Gajra A, Newman N, Gamble GP, Abraham NZ, Kohman LJ, Graziano SL, et al. Impact of tumor size on survival in stage 1A non-small cell lung cancer: a case for subdividing stage 1A disease. Lung Cancer. 2003;42:51–57
  32. Garfield DH, Cadranel JL, Wislez M, Franklin WA, Hirsch FR. The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases. J Thorac Oncol. 2006;1:344–359
  33. Travis WD, Garg K, Franklin WA, Wistuba II, Sabloff B, Noguchi M, et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol. 2005;23:3279–3287
  34. Wisnivesky JP, Yankelevitz D, Henschke CI. The effect of tumor size on curability of Stage I non-small-cell lung cancers. Chest. 2004;126:761–765
  35. Watanabe S, Oda M, Go T, Tsunezuka Y, Ohta Y, Watanabe Y, et al. Should mediastinal nodal dissection be routinely undertaken in patients with peripheral small-sized (2cm or less) lung cancer? Retrospective analysis of 225 patients. Eur J Cardiothorac Surg. 2001;20:1007–1011

PII: S0169-5002(07)00402-3

doi: 10.1016/j.lungcan.2007.06.022

Lung Cancer
Volume 58, Issue 3 , Pages 329-341 , December 2007

Article Tools

* Image Usage & Resolution